Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Publisher Name :
Date: 8-Apr-2013
No. of pages: 158

Global Molecular Diagnostics Market & Future Forecast to 2017 Overview

The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.

Molecular Diagnostics Market – Application Segment Analysis

•    The infectious disease testing is the leading application in Molecular Diagnostic. It is likely to hold XXXX% share in 2017.
•    Molecular oncology tests have emerged as a second significant rapidly growing market segment. Genetic Testing and Blood Screening are at the third and fourth spot respectively in 2012.
•    The cardiovascular disease testing and neurological testing are closely competing with each other to gain the maximum market share.
•    Food testing market is expected to inch up to US$ XXXX Million in 2017.
Technologies Segment Analysis
•    Biochips and PCR based test accounts for the largest shares in the molecular diagnostics technologies segment with XXXX% and XXXX% respectively in 2012.
•    Fish & Innovations technology market is at the 3rd slot.
•    The PCR related technologies and Non- PCR market is at the 4th and 5th position respectively.
•    The biosensor and Molecular Imaging technology are also showing impressive growth.
Geographical Analysis
•    United States molecular diagnostic market is expected to be more than double by 2017 from its current market in 2012.
•    Europe stands at the second position in the global molecular diagnostic market.
•    China, Japan and India are expected to stand at 3rd, 4th and 5th slot respectively.
•    The Mexico molecular diagnostics market is predicted to grow at a CAGR of 17% between 2012 and 2017.
Company Wise Analysis
•    The Roche molecular diagnostic share is greater than the combined share of Myriad Genetics and Qiagen which holds the 2nd and 3rd position respectively.
•    Abbott stands at the 4th spot and expected to generate sales worth US$ XXXX Million by the year 2017.
•    The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.

Renub Research study titled “Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics market. This 158 page report with 81 Figures and 23 Tables studies the Global Molecular Diagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trials In Molecular Diagnostics Landscape.

The Report Covers the Following Points
•    Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017)
•    Global Molecular Diagnostic Application Segment (Infectious Disease Testing, Virology Testing, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening, Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing, Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies , Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, Molecular Imaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Geographical Distribution (US, Europe, China, Japan, India, Brazil, Mexico, South Korea and Rest of World) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic and Road to Personalized medicine
•    Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report)
•    Driving Forces & Challenges for Global Molecular Diagnostic Market

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market & Forecast - (2010 - 2017)

3. Molecular Diagnostics Market Share - (2010 - 2017)
3.1 Share & Forecast - Application Wise
3.2 Share & Forecast - Technology Wise
3.3 Share & Forecast - Region Wise
3.4 Share & Forecast - Company Wise

4. Molecular Diagnostics Market (Application Segment) - (2010 - 2017)
4.1 Infectious Disease Testing Market & Forecast
4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast
4.1.2 Health - Associated Infections (HAI) Testing Market & Forecast
4.1.3 HPV Testing Market & Forecast
4.1.4 Critical Care Infectious Testing Market & Forecast
4.2 Blood Screening Market & Forecast
4.3 Genetic Testing Market & Forecast
4.4 Oncology Testing Market & Forecast
4.5 Tissue Typing (HLA Testing) Market & Forecast
4.6 Cardiovascular Disease Testing Market & Forecast
4.7 Neurological Disorders Testing Market & Forecast
4.8 Food Pathogen Detection Testing Market & Forecast
4.9 Miscellaneous Testing Market & Forecast

5. Molecular Diagnostics Market (Technologies Segment) - (2010 - 2017)
5.1 PCR Based Test Market & Forecast
5.2 PCR Related Technologies Market & Forecast
5.3 Non-PCR Test Market & Forecast
5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast
5.5 Biochips/Microarrays Market & Forecast
5.6 Biosensors Market & Forecast
5.7 Molecular Imaging Market & Forecast
5.8 Other Technologies Market & Forecast

6. Geographical Distribution - Molecular Diagnostics Market - (2008 - 2017)
6.1 United States Molecular Diagnostics Market & Forecast
6.2 Europe Molecular Diagnostics Market & Forecast
6.3 China Molecular Diagnostics Market & Forecast
6.4 Japan Molecular Diagnostics Market & Forecast
6.5 India Molecular Diagnostics Market & Forecast
6.6 Brazil Molecular Diagnostics Market & Forecast
6.7 Mexico Molecular Diagnostics Market & Forecast
6.8 South Korea Molecular Diagnostics Market & Forecast
6.9 Rest of World Molecular Diagnostics Market & Forecast

7. Molecular Diagnostics Market (Company Wise) - (2010 - 2017)
7.1 Roche Molecular Diagnostics Market & Forecast
7.2 Abbott Molecular Diagnostics Market & Forecast
7.3 Myriad Genetics Molecular Diagnostics Market & Forecast
7.4 Qiagen Molecular Diagnostics Market & Forecast
7.5 BioMérieux Molecular Diagnostics Market & Forecast
7.6 Other Companies Molecular Diagnostics Market & Forecast

8. Molecular Diagnostics and Personalized Medicine
8.1 Road to Personalized Medicine
8.1.1 Historical perspective: HIV & Oncology
8.1.2 Other Applications: Met & Unmet Therapy Areas
8.2 Molecular Diagnostics Technologies
8.2.1 Expression Profiling - RNA & Pharmacogenomics
8.2.2 Expression Profiling - Proteins & Pharmacoproteomics
8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis
8.2.4 DNA Sequence Profiling - High-Throughput Sequencing
8.3 Molecular Diagnostics and Personalized Medicine: Value-Assessed Opportunities for Multiple Stakeholders Values, Needs & Expectations
8.4 Regulatory Authorities
8.5 Molecular Diagnostics as Companion Diagnostics: Value-Driven Adoption
8.5.1 Behavioral Impact
8.5.2 Economic Impact (Value-Based vs. Cost-Plus Pricing)

9. Molecular Diagnostics Clinical Trial Statement
9.1 Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
9.2 Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase (ALK) Translocation
9.3 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus
9.4 Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
9.5 A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test
9.6 Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma
9.7 Biopsies of Cancer Patients for Tumor Molecular Characterization
9.8 Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
9.9 Collection of Tissue Samples for Cancer Research
9.10 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
9.11 Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia
9.12 Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy
9.13 Congenital Muscle Disease Study of Patient and Family Reported Medical Information
9.14 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates
9.15 Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
9.16 CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
9.17 Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
9.18 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
9.19 Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
9.20 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

10. Molecular Diagnostics Market - Drivers
10.1 Various Developments in the Molecular Diagnostics Landscape
10.2 Increasing Investment in Genomics & Proteomics Research
10.3 Technological Advances in Molecular Diagnostics
10.4 Increasing Acceptance of the Personalized Medicine
10.5 Growing Molecular Diagnostics for Food Safety

11. Molecular Diagnostics Market - Challenges
11.1 Regulatory Issues
11.2 Various Factors Slowing Growth of Molecular Diagnostics
11.3 Reimbursement Capabilities
11.4 Quality Checkpoints, Awareness & Acceptance

List of Tables
Table 3 1: Global Molecular Diagnostics - Company Wise Market Share (Percent), 2010 - 2012
Table 3 2: Global Molecular Diagnostics - Forecast for Company Wise Market Share (Percent), 2013 - 2017
Table 8 1: Molecular Platforms for Companion Diagnostics
Table 9 1: Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples - Clinical Trials, 2012
Table 9 2: Crizotinib Efficacy in Non-Small Cell Lung Cancer Patients with Anaplastic Lymphoma Kinase Translocation - Clinical Trials, 2012
Table 9 3: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus - Clinical Trials, 2012
Table 9 4: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler - Clinical Trials, 2012
Table 9 5: A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test - Clinical Trials, 2013
Table 9 6: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma - Clinical Trials, 2012
Table 9 7: Biopsies of Cancer Patients for Tumor Molecular Characterization - Clinical Trails, 2012
Table 9 8: Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia - Clinical Trials, 2013
Table 9 9: Collection of Tissue Samples for Cancer Research - Clinical Trials, 2012
Table 9 10: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma - Clinical Trials, 2012
Table 9 11: Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia - Clinical Trials, 2012
Table 9 12: Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy, 2013
Table 9 13: Congenital Muscle Disease Study of Patient and Family Reported Medical Information - Clinical Trials, 2013
Table 9 14: Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates - Clinical Trials, 2013
Table 9 15: Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase - Clinical Trials, 2012
Table 9 16: CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib - Clinical Trial, 2013
Table 9 17: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile - Clinical Trials, 2013
Table 9 18: Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients - Clinical Trials, 2012
Table 9 19: Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients - Clinical Trials, 2012
Table 9 20: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) - Clinical Trials, 2012

List of Figures
Figure 2 1: Global - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 2 2: Global - Forecast for Molecular Diagnostics Industry (Million US$), 2013 - 2017
Figure 3 1: Global Molecular Diagnostics - Application Wise Market Share (Percent), 2010 - 2012
Figure 3 2: Global Molecular Diagnostics - Forecast for Application Wise Market Share (Percent), 2013 - 2017
Figure 3 3: Global Molecular Diagnostics - Technology Wise Market Share (Percent), 2010 - 2012
Figure 3 4: Global Molecular Diagnostics - Forecast for Technology Wise Market Share (Percent), 2013 - 2017
Figure 3 5: Global Molecular Diagnostics - Region Wise Market Share (Percent), 2010 - 2012
Figure 3 6: Global Molecular Diagnostics - Forecast for Region Wise Market Share (Percent), 2013 - 2017
Figure 4 1: Global - Infectious Disease Testing Market (Million US$), 2010 - 2012
Figure 4 2: Global - Forecast for Infectious Disease Testing Market (Million US$), 2013 - 2017
Figure 4 3: Global - Virology Testing Market (Million US$), 2010 - 2012
Figure 4 4: Global - Forecast for Virology Testing Market (Million US$), 2013 - 2017
Figure 4 5: Global - HAI Testing Market (Million US$), 2010 - 2012
Figure 4 6: Global - Forecast for HAI Testing Market (Million US$), 2013 - 2017
Figure 4 7: Global - HPV Testing Market (Million US$), 2010 - 2012
Figure 4 8: Global - Forecast for HPV Testing Market (Million US$), 2013 - 2017
Figure 4 9: Global - Critical Care Infectious Testing Market (Million US$), 2008 - 2012
Figure 4 10: Global - Forecast for Critical Care Infectious Testing Market (Million US$), 2013 - 2017
Figure 4 11: Global - Blood Screening Market (Million US$), 2007 - 2012
Figure 4 12: Global - Forecast for Blood Screening Market (Million US$), 2013 - 2017
Figure 4 13: Global - Genetic Testing Market (Million US$), 2010 - 2012
Figure 4 14: Global - Forecast for Genetic Testing Market (Million US$), 2013 - 2017
Figure 4 15: Global - Oncology Market (Million US$), 2010 - 2012
Figure 4 16: Global - Forecast for Oncology Market (Million US$), 2013 - 2017
Figure 4 17: Global - Tissue Typing Market (Million US$), 2008 - 2012
Figure 4 18: Global - Forecast for Tissue Typing Market (Million US$), 2013 - 2017
Figure 4 19: Global - Cardiovascular Disease Testing Market (Million US$), 2010 - 2012
Figure 4 20: Global - Forecast for Cardiovascular Disease Testing Market (Million US$), 2013 - 2017
Figure 4 21: Global - Neurological Disorders Testing Market (Million US$), 2010 - 2012
Figure 4 22: Global - Forecast for Neurological Disorders Testing Market (Million US$), 2013 - 2017
Figure 4 23: Global - Food Pathogen Detection Testing Market (Million US$), 2010 - 2012
Figure 4 24: Global - Forecast for Food Pathogen Detection Testing Market (Million US$), 2013 - 2017
Figure 4 25: Global - Miscellaneous Testing Market (Million US$), 2010 - 2012
Figure 4 26: Global - Forecast for Miscellaneous Testing Market (Million US$), 2013 - 2017
Figure 5 1: Global - PCR Based Test Market (Million US$), 2010 - 2012
Figure 5 2: Global - Forecast for PCR Based Test Market (Million US$), 2013 - 2017
Figure 5 3: Global - PCR Related Technologies Market (Million US$), 2010 - 2012
Figure 5 4: Global - Forecast for PCR Related Technologies Market (Million US$), 2013 - 2017
Figure 5 5: Global - Non-PCR Test Market (Million US$), 2010 - 2012
Figure 5 6: Global - Forecast for Non-PCR Test Market (Million US$), 2013 - 2017
Figure 5 7: Global - Fish & Innovations Market (Million US$), 2010 - 2012
Figure 5 8: Global - Forecast for Fish & Innovations Market (Million US$), 2013 - 2017
Figure 5 9: Global - Biochips/ Microarrays Market (Million US$), 2010 - 2012
Figure 5 10: Global - Forecast for Biochips/Micrroarrays Market (Million US$), 2013 - 2017
Figure 5 11: Global - Biosensors Market (Million US$), 2010 - 2012
Figure 5 12: Global - Forecast for Biosensors Market (Million US$), 2013 - 2017
Figure 5 13: Global - Molecular Imaging Market (Million US$), 2010 - 2012
Figure 5 14: Global - Forecast for Molecular Imaging Market (Million US$), 2013 - 2017
Figure 5 15: Global - Other Technologies Market (Million US$), 2010 - 2012
Figure 5 16: Global - Forecast for Other Technologies Market (Million US$), 2012 - 2017
Figure 6 1: US - Molecular Diagnostics Market (Million US$), 2002 - 2012
Figure 6 2: US - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 3: Europe - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 4: Europe - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 5: China - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 6: China - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 7: Japan - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 8: Japan - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 9: India - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 10: India - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 11: Brazil - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 12: Brazil - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 13: Mexico - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 14: Mexico - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 15: South Korea - Molecular Diagnostics Market (Million US$), 2005 - 2012
Figure 6 16: South Korea - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 17: Rest of World - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 18: Rest of World - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 7 1: Roche - Molecular Diagnostics Sales (Million US$), 2008 - 2012
Figure 7 2: Roche - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 3: Abbott - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 4: Abbott - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 5: Myriad Genetics - Molecular Diagnostics Sales (Million US$), 2007 - 2012
Figure 7 6: Myriad Genetics - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 7: Qiagen - Molecular Diagnostics Sales (Million US$), 2009 - 2012
Figure 7 8: Qiagen - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 9: BioMérieux - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 10: BioMérieux - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 11: Other Companies - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 12: Other Companies - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 8 1: A Healthcare ‘Value-Net

 

  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Cervical Cancer Diagnostic Tests Market 2014-2018
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 103
    About Cervical Cancer Diagnostic Tests Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer. TechNavio's analysts forecast......
  • MediPoint: Nuclear Imaging- PET and SPECT Equipment – Global Analysis and Market Forecasts
    Published: 15-Dec-2014        Price: US $6495 Onwards        Pages: 318
    This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET i......
  • 2014 Deep Research Report on Global Polarimeter Industry
    Published: 15-Dec-2014        Price: US $2600 Onwards        Pages: 129
    This is a professional and depth research report on Global Polarimeter industry. For overview analysis, the report introduces Polarimeter basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Polarimeter markets in China and other countries or regions (such as US, Europe, Japan, etc.) by presenting research on global products ......
  • Global Digital X-ray Market 2015-2019
    Published: 10-Dec-2014        Price: US $2500 Onwards        Pages: 92
    Digital X-ray systems are used for diagnosing and treatment of diseases by creating and recording images. The X-ray images captured using a digital system are no different from that of screen-film radiography. In a digital system, screen-film detectors and sensors generate the digital image. Digital detectors allow full implementation of image archiving and communication; these images can be transferred from one operational unit to another, and can be accessed by means of web-based technology wi......
  • Allergy Diagnostics Market by Allergen Source (Food Allergens, Inhaled Allergens), Product (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) & by End User (Hospital, Diagnostic Laboratory) – Global Forecast to 2019
    Published: 8-Dec-2014        Price: US $4650 Onwards        Pages: 210
    Allergy diagnostics is used to determine the nature and treatment course of allergic diseases. According to an editorial piece published in the World Allergy Journal in May 2014, about 300 million people suffered from asthma and about 200 to 250 million people suffered from food allergies in 2013. The prevalence of asthma has risen rapidly across the globe. According to the World Health Organization (WHO), about 300 million asthma cases were recorded globally in 2013 and are expected to increase......
  • 2014 Deep Research Report on Global Nuclear Magnetic Resonance Spectrometer (NMR) Industry
    Published: 2-Dec-2014        Price: US $2200 Onwards        Pages: 109
    This is a professional and depth research report on Global Nuclear Magnetic Resonance Spectrometer (NMR) industry. For overview analysis, the report introduces Nuclear Magnetic Resonance Spectrometer (NMR) basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Nuclear Magnetic Resonance Spectrometer (NMR) markets in China and o......
  • China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
    Published: 2-Dec-2014        Price: US $1400 Onwards        Pages: 77
    This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points: 1) Market and Forecast 2) Segment Wise Market & Forecast 3) Development Environment & Regulatory Status in China IVD market 4) Company......
  • In Vitro Diagnostics Markets in China
    Published: 1-Dec-2014        Price: US $4000 Onwards        Pages: 168
    China's demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity......
  • Cancer Diagnostics Partnering Terms and Agreements
    Published: 1-Dec-2014        Price: US $2995 Onwards        Pages: 1290
    The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value The Cancer Diagnostics Partnering Agreements report provides an unders......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs